|
EVGN Evogene Ltd 1574565 |
| Balance Sheet |
|
Current Assets
|
$15,631,000.00 |
|
Assets
|
$20,046,000.00 |
|
Current Liabilities
|
$3,444,000.00 |
|
Liabilities
|
$8,071,000.00 |
|
Equity
|
$11,975,000.00 |
|
Shares Out
|
8718193.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-13,502,000.00 |
|
Investing Cash Flow
|
$17,738,000.00 |
| Market Analysis |
Market Cap
|
$4,271,914.57 |
|
Price
|
$0.46 |
|
BVPS
|
1.37 |
|
PB
|
0.36 |
|
EPS
|
-1.38 |
|
PS
|
0.97 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:46 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.61 |
|
|
2026-05-20 |
-0.60 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-19 |
-0.50 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-20 |
0.75 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EVGN documents filed with the SEC.
EVGN Filings
Clear
